This legislation aims to enhance transparency and safety within the aviation sector by requiring the Federal Aviation Administration (FAA) to make public a comprehensive list of medications. Its primary purpose is to ensure that airmen , air traffic control specialists , and those in training are clearly informed about which medications are safely prescribed and approved for medical certification purposes. Within one year of enactment, the FAA Administrator must publish and continuously maintain this list on a publicly accessible website. To ensure its medical appropriateness and user-friendliness, the list must be developed in consultation with various stakeholders, including the Aeromedical Innovation and Modernization Working Group, higher education institutions, and representatives of air traffic controllers and airline pilots. It will cover all approved medications, both prescription and over-the-counter , and indicate any required duty limitations for stabilization on a medication. Furthermore, the list must include medications designated as "Do Not Issue" and provide contact information for medical providers, with annual updates mandated to keep the information current.
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Transportation and Public Works
Aviation Medication Transparency Act of 2025
USA119th CongressS-3258| Senate
| Updated: 11/20/2025
This legislation aims to enhance transparency and safety within the aviation sector by requiring the Federal Aviation Administration (FAA) to make public a comprehensive list of medications. Its primary purpose is to ensure that airmen , air traffic control specialists , and those in training are clearly informed about which medications are safely prescribed and approved for medical certification purposes. Within one year of enactment, the FAA Administrator must publish and continuously maintain this list on a publicly accessible website. To ensure its medical appropriateness and user-friendliness, the list must be developed in consultation with various stakeholders, including the Aeromedical Innovation and Modernization Working Group, higher education institutions, and representatives of air traffic controllers and airline pilots. It will cover all approved medications, both prescription and over-the-counter , and indicate any required duty limitations for stabilization on a medication. Furthermore, the list must include medications designated as "Do Not Issue" and provide contact information for medical providers, with annual updates mandated to keep the information current.